Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping'an Ding

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
BMC Gastroenterology|January 23, 2023
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinibPing'an Ding, Jiaxiang Wu, Haotian Wu, et al.
Frontiers in Oncology|October 31, 2022
Impact of skeletal muscle loss during conversion therapy on clinical outcomes in lavage cytology positive patients with gastric cancerPing'an Ding, Peigang Yang, Li Yang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 25, 2023
A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal TumorsHaotian Wu, Ping'an Ding, Jiaxiang Wu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 21, 2024
Impact of preoperative sarcopenia on postoperative complications and prognosis in patients undergoing robotic gastric cancer surgery: A propensity score matching studyPing'an Ding, Haotian Wu, Tongkun Li, et al.
BMC Gastroenterology|August 26, 2022
Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GISTPing'an Ding, Honghai Guo, Xiaoxiao He, et al.
BMC Cancer|August 15, 2024
Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective studyPing'an Ding, Jiaxuan Yang, Jiaxiang Wu, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective studyPing'an Ding, Peigang Yang, Yuan Tian, et al.
BMC Cancer|April 21, 2025
Association of low skeletal muscle mass and radiodensity with clinical outcomes in patients undergoing robotic radical gastric cancer surgery: a population-based retrospective cohort studyHonghai Guo, Sheng Chen, Tao Zheng, et al.
Frontiers in Nutrition|February 21, 2022
Relationship Between Nutritional Status and Clinical Outcome in Patients With Gastrointestinal Stromal Tumor After Surgical ResectionPing'an Ding, Honghai Guo, Chenyu Sun, et al.
Frontiers in Oncology|September 12, 2022
Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trialHonghai Guo, Ping'an Ding, Chenyu Sun, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
BMC Gastroenterology|January 23, 2023
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinibPing'an Ding, Jiaxiang Wu, Haotian Wu, et al.
Frontiers in Oncology|October 31, 2022
Impact of skeletal muscle loss during conversion therapy on clinical outcomes in lavage cytology positive patients with gastric cancerPing'an Ding, Peigang Yang, Li Yang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 25, 2023
A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal TumorsHaotian Wu, Ping'an Ding, Jiaxiang Wu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 21, 2024
Impact of preoperative sarcopenia on postoperative complications and prognosis in patients undergoing robotic gastric cancer surgery: A propensity score matching studyPing'an Ding, Haotian Wu, Tongkun Li, et al.
BMC Gastroenterology|August 26, 2022
Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GISTPing'an Ding, Honghai Guo, Xiaoxiao He, et al.
BMC Cancer|August 15, 2024
Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective studyPing'an Ding, Jiaxuan Yang, Jiaxiang Wu, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective studyPing'an Ding, Peigang Yang, Yuan Tian, et al.
BMC Cancer|April 21, 2025
Association of low skeletal muscle mass and radiodensity with clinical outcomes in patients undergoing robotic radical gastric cancer surgery: a population-based retrospective cohort studyHonghai Guo, Sheng Chen, Tao Zheng, et al.
Frontiers in Nutrition|February 21, 2022
Relationship Between Nutritional Status and Clinical Outcome in Patients With Gastrointestinal Stromal Tumor After Surgical ResectionPing'an Ding, Honghai Guo, Chenyu Sun, et al.
Frontiers in Oncology|September 12, 2022
Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trialHonghai Guo, Ping'an Ding, Chenyu Sun, et al.
Pageof 5